Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
21 CFR Part 111 Dietary Supplement cGMP. Available at: FDA
CJC-1295 (no DAC): GHRH analogue stimulates pituitary GH release Ipamorelin: selective GHRP with minimal cortisol/prolactin effect Synergistic GH release 35 greater than either peptide alone Pulsatile GH pattern preservation in research models Widely used combination in GH axis research protocols Research reference CJC-1295 (no DAC) + Ipamorelin Blend Dosage Published Research Protocols The following reference points are drawn from published research literature
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) improve biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomised controlled trials
Sample preparation was performed in Brand PCR 96-well plates
By combining Sermorelin, a functional 29-amino acid fragment of endogenous Growth Hormone Releasing Hormone (GHRH), with Ipamorelin, a highly selective pentapeptide growth hormone secretagogue (GHS), this blend allows researchers to investigate enhanced secretagogue dynamics
US$ 25.00
US$ 20.99
US$ 21.53
US$ 29.74
US$ 25.07
US$ 23.52
US$ 20.23
US$ 22.63
